Location History:
- Wuppertal, DE (2006 - 2011)
- Wolfegg, DE (2015 - 2017)
Company Filing History:
2 out of 721 
1 out of 12,164 
1 out of 192 
Years Active: 2006-2017
Title: Verena Vöhringer: Innovator in Pharmaceutical Chemistry
Introduction
Verena Vöhringer is a prominent inventor based in Wolfegg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating cancer and other proliferative disorders. With a total of 4 patents to her name, her work has the potential to impact the medical community significantly.
Latest Patents
One of her latest patents is titled "Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment of cancer." This invention focuses on novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives that exhibit protein tyrosine kinase inhibitory activities. The patent details processes for preparing these compounds, pharmaceutical compositions containing them, and their application in treating proliferative disorders, particularly cancer and tumor diseases.
Another significant patent is "Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors." This invention relates to novel 5-[(hydroxymethyl)aryl]-substituted pyrrolo[2,1-f][1,2,4]triazin-4-amines. It includes processes for their preparation, pharmaceutical compositions, and their use in treating angiogenesis-related disorders, especially those affecting ocular health.
Career Highlights
Verena has worked with notable companies in the pharmaceutical sector, including Bayer Intellectual Property GmbH and Bayer Aktiengesellschaft. Her experience in these organizations has allowed her to develop her innovative ideas into practical applications.
Collaborations
Throughout her career, Verena has collaborated with esteemed colleagues such as Mario Lobell and Volkhart Min-Jian Li. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Verena Vöhringer is a trailblazer in pharmaceutical chemistry, with a focus on developing innovative treatments for cancer and related disorders. Her patents reflect her commitment to advancing medical science and improving patient outcomes.